Oxcarbazepine Tablet, Film Coated
Product Images NDC 72162-1594

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 72162-1594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621594)

Oxcarbazepine Tablets USP 300 mg film-coated tablets label. The label includes storage instructions, a warning to keep out of reach of children, and a note about the color additive tartrazine. It indicates the product is relabeled by Bryant Ranch Prepack and manufactured by LGM Pharma Solutions, LLC. The package contains 500 tablets and is marked Rx only with NDC 72162-1594-5.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure diagram of oxcarbazepine, depicting its bicyclic ring system with a ketone group (=O) and an amide substituent (CONH2) attached to the nitrogen atom.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier survival curve showing exit rates over time from Day 2 to Day 11 for treatment groups receiving Oxcarbazepine and placebo. The solid line represents Oxcarbazepine, and the dotted line represents placebo. A log-rank test p-value of 0.0001 is noted on the graph, indicating a statistically significant difference between the groups.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier survival curve graph comparing seizure rates over time between two treatment groups, Oxcarbazepine and Placebo. The x-axis measures days from the first dose to the first seizure, and the y-axis represents the seizure rate. The graph includes a log-rank test p-value of 0.046 indicating statistical comparison between the groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A survival curve chart showing exit rate over time (days) for two treatment groups labeled HIGH (solid line) and LOW (dashed line). The exit rate is plotted on the vertical axis from 0 to 1, and the horizontal axis shows time to exit in days up to 130. The chart includes a log-rank test p-value of 0.0001.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier plot depicting exit rate versus time to exit in days, comparing two treatment groups labeled as HIGH and LOW. The graph includes a log-rank test p-value of 0.0001, indicating statistical analysis between the groups. The x-axis represents time to exit in days, and the y-axis represents the exit rate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.